← Open Payments lookup

ASHLEY MELUGIN: Open Payments

NPI 1881094902 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,696 in 176 payments from 12 companies in 2025. Trend: 2023 $2,235 · 2024 $2,191 · 2025 $2,696

Food & beverage: $2,696
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.27$493
Neurocrine BioSciences, Inc.31$432
Otsuka America Pharmaceutical, Inc.28$347
Janssen Pharmaceuticals, Inc22$344
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$296
Vanda Pharmaceuticals Inc.13$285
Alkermes, Inc.14$172
ABBVIE INC.10$144
Axsome Therapeutics, Inc.4$75
E.R. Squibb & Sons, L.L.C.3$51

Products named: INGREZZA, UZEDY, CAPLYTA, REXULTI, INVEGA SUSTENNA, FANAPT, AUSTEDO XR, ARISTADA.

Industry payments across KS — which companies pay providers there.